Fellow - Nuclear Medicine - Radionuclide Therapy
MELBOURNE, VIC, AU, 3000
Radionuclide Therapy Fellow
Cancer Imaging Department
Peter MacCallum Cancer Centre
Full time – 12 months Contract commencing 3 February 2025
Eligible and enthusiastic candidates are encouraged to apply for this position now open at Peter MacCallum Cancer Centre – a place where our normal days are extraordinary; as are the people we care for. This would be an ideal opportunity for nuclear medicine trainees who have completed their core training and seek further experience in radionuclide therapy. Radiation oncology and medical oncology trainees who have completed their core training and are interested in Lu-PSMA and Lu-Tate therapy as well as accredited endocrinology trainees with interest in thyroid cancer and Lu-Tate therapy in rare endocrine syndromes and functional neuroendocrine tumours would also be suitable candidates for this role.
Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best in cancer care, even better treatments and potential cancer cures for all people affected by cancer.
Globally, we are facing one of the most pivotal times in the pursuit of cancer cures, and Peter Mac stands at its forefront. Together, we aim to lead a new era of cancer prevention, care and discovery, supported by state-of-the-art facilities at our new home within the Victorian Comprehensive Cancer Centre building.
Your role in our future
We have an integrated large radionuclide therapy facility for both outpatient and inpatient care including paediatrics. We performed over 800 radionuclide therapies in 2022 with Lu-177, I-131 and Y-90 for malignancies including neuroendocrine, prostate, thyroid and lymphoma. Our Cancer Imaging centre provides a high-level service in cancer diagnosis, staging, therapeutic monitoring and research. We perform more than 9500 PET/CT scans per annum including many non-FDG studies with various radiotracers such as F-18, Ga-68, Cu-64, I-124 and Zr-89 for both clinical and research purposes including first in-human studies.
You would be working in therapeutic nuclear medicine, which is mostly an outpatient service, and primarily involved in patient’s initial visit, ongoing therapy and follow up with opportunities to be involved in research. Participation in pre-existing or new research projects for presentation or publication is strongly encouraged.
The Training position is not accredited by the AANMS for a core year of advanced training in nuclear medicine.
A medical degree and AHPRA registration are pre-requisites for appointment. You will need to either have completed one year of accredited core training in nuclear medicine or completed your core training years in medical oncology, radiation oncology or endocrinology.
Peter Mac offers its employees the following benefits:
• Salary Packaging
• Central City Location
• Employee Assistance Program
• Training and Development Program
Applicants to this role should provide a covering letter outlining relative key skills and experience to assist us with our assessment.
For further information about this opportunity, click Apply to be redirected to the Peter Mac Careers page where you can review the position summary. Alternatively, please contact us using the information below for a confidential discussion.
Hiring Manager: Ramin Alipour
Contact Number: 8559 5000
Email: Ramin.Alipour@petermac.org
Applications close: 20 May 2024
Position Summary
• Nuclear medicine radionuclide therapeutic program
• Involvement in Multidisciplinary Tumour Stream meetings
• Diagnostic program of the nuclear medicine service
• Pre-clinical or laboratory research
Enterprise Agreement
Doctors in Training
Classification or Salary Range
TBA (classification in accordance with experience)
Immunisation Risk Category
Category A: Position involving direct patient contact, potential for exposure to blood, body fluid, human tissue specimens during course of a normal working day
Key Relationships
Internal:
• Cancer Imaging Nuclear Medicine Technologists
• Clinicians
• Researchers
External:
• Patients
• Referring Clinicians
Skills
Essential Requirements:
• Medical Registration with AHPRA
• FRACP Part 1 or FRANZCR Part 2, or equivalent training in recognized training program
• Completion of at least one core year of nuclear medicine training, as accredited by JCTC or the equivalent, is preferred
Desirable Requirements:
• Completion of 2-core years of nuclear medicine training, as accredited by JCTC or the equivalent, is highly desirable.
• The position may also be suitable as an elective year of training for advanced trainees in endocrinology or medical oncology.
Certifications, Licenses & Registrations
Key Accountabilities
| Demonstrated by / Key Performance Indicators | |
| 1. Perform and Interpret Diagnostic procedures |
• Understand protocols as applicable to Oncology. |
| 2. Perform Therapeutic Administrations |
• Evaluate patients suitability for radionuclide therapy within or outside clinical trials |
| 3. Radiation Safety and Quality Assurance |
• Understand Department QA activities and their relevance to staff and patient safety |
| 4. Clinical Meetings |
• Prepare and interpret Nuclear Medicine and PET images for presentation at clinical meetings |
______________________________________________________________________________________________________
For further information about this opportunity, click Apply to be redirected to the Peter Mac Careers page where you can review the position profile. Alternatively, please contact us for a confidential discussion.
Peter Mac requires its staff to be fully vaccinated against COVID-19. Please contact us if you would like to discuss this requirement.
WHY WORK FOR PETER MAC
- Peter Mac offer a range of benefits which support our people both personally and professionally.
- Our staff benefits include award winning facilities, professional development and events, a health and wellbeing program, flexible work practices and policies and financial benefits such as salary packaging.
- We encourage applications from Aboriginal and Torres Strait Islander people, all members of the LGBTQI community and people with a disability.